Corrigendum to “Novel 2,3,4,5-tetrahydro-benzo[<em>d</em>]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models” [Bioorg. Med. Chem. Lett. 21 (2011) 463]期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Corrigendum to “Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models” [Bioorg. Med. Chem. Lett. 21 (2011) 463]

Authors:	Eugen F. Mesaros Jason P. BurkeJonathan D. Parrish Benjamin J. DuganAndrew V. Anzalone Thelma S. AngelesMark S. Albom Lisa D. AimoneMatthew R. Quail Weihua WanLihui Lu Zeqi HuangMark A. Ator Bruce A. RuggeriMangeng Cheng Gregory R. Ott Bruce D. Dorsey

Affiliation:	Worldwide Discovery Research, Cephalon, Inc., 145 Brandywine Parkway, West Chester, PA 19380, USA

Abstract:

Keywords:
本文献已被 ScienceDirect 等数据库收录！